Literature DB >> 19786207

Iron sequestration and anemia of inflammation.

Tomas Ganz1, Elizabeta Nemeth.   

Abstract

Anemia of chronic disease, also called anemia of inflammation, is characterized by hypoferremia due to iron sequestration that eventually results in iron-restricted erythropoiesis. During the last decade, the molecular mechanisms of iron sequestration have been found to center on cytokine-stimulated overproduction of the iron-regulatory hormone hepcidin. The inflammatory cytokine interleukin-6 (IL-6) is a particularly prominent inducer of hepcidin, but other cytokines are likely to contribute as well. Hepcidin excess causes the endocytosis and proteolysis of the sole known cellular iron exporter, ferroportin, trapping iron in macrophages and iron-absorbing enterocytes. The supply of iron to hemoglobin synthesis becomes limiting, eventually resulting in anemia. Depending on the details of the underlying disease, other inflammation-related mechanisms may also contribute to anemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786207      PMCID: PMC2755591          DOI: 10.1053/j.seminhematol.2009.06.001

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  77 in total

1.  THE ANEMIA OF INFECTION. I. HYPOFERREMIA, HYPERCUPREMIA, AND ALTERATIONS IN PORPHYRIN METABOLISM IN PATIENTS.

Authors:  G E Cartwright; M A Lauritsen; P J Jones; I M Merrill; M M Wintrobe
Journal:  J Clin Invest       Date:  1946-01       Impact factor: 14.808

2.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

3.  Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia.

Authors:  Antonio Macciò; Clelia Madeddu; Daniela Massa; Maria C Mudu; Maria R Lusso; Giulia Gramignano; Roberto Serpe; Gian Benedetto Melis; Giovanni Mantovani
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

4.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

6.  Inflammation triggers hypoferremia and de novo synthesis of serum transferrin and ceruloplasmin in mice.

Authors:  D L Beaumier; M A Caldwell; B E Holbein
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 7.  Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.

Authors:  Yoshiyuki Ohsugi
Journal:  Biol Pharm Bull       Date:  2007-11       Impact factor: 2.233

Review 8.  Iron and liver cancer.

Authors:  Yves Deugnier
Journal:  Alcohol       Date:  2003-06       Impact factor: 2.405

9.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

10.  Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis.

Authors:  Ulrich E Schaible; Helen L Collins; Friedrich Priem; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  112 in total

1.  Hepcidin, anaemia, and prostate cancer.

Authors:  Toshihiko Tanno; Antoinette Rabel; Michael Alleyne; Y Terry Lee; William L Dahut; James L Gulley; Jeffery L Miller
Journal:  BJU Int       Date:  2011-02       Impact factor: 5.588

2.  The association between low-grade inflammation, iron status and nucleic acid oxidation in the elderly.

Authors:  Kasper Broedbaek; Volkert Siersma; Jon T Andersen; Morten Petersen; Shoaib Afzal; Brian Hjelvang; Allan Weimann; Richard D Semba; Luigi Ferrucci; Henrik E Poulsen
Journal:  Free Radic Res       Date:  2011-01-28

Review 3.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 4.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

6.  Suppression of iron-regulatory hepcidin by vitamin D.

Authors:  Justine Bacchetta; Joshua J Zaritsky; Jessica L Sea; Rene F Chun; Thomas S Lisse; Kathryn Zavala; Anjali Nayak; Katherine Wesseling-Perry; Mark Westerman; Bruce W Hollis; Isidro B Salusky; Martin Hewison
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

7.  Hepcidin expression in colon during trinitrobenzene sulfonic acid-induced colitis in rats.

Authors:  Érica Martins Ferreira Gotardo; Gilberto de Almeida Ribeiro; Thayane Rodrigues Leite Clemente; Camila Henrique Moscato; Renata Bortolin Guerra Tomé; Thalita Rocha; José Pedrazzoli; Marcelo Lima Ribeiro; Alessandra Gambero
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 8.  Research review: maternal prenatal distress and poor nutrition - mutually influencing risk factors affecting infant neurocognitive development.

Authors:  Catherine Monk; Michael K Georgieff; Erin A Osterholm
Journal:  J Child Psychol Psychiatry       Date:  2012-10-05       Impact factor: 8.982

Review 9.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  Maternal Perceived Stress during Pregnancy Increases Risk for Low Neonatal Iron at Delivery and Depletion of Storage Iron at One Year.

Authors:  Danielle N Rendina; Sharon E Blohowiak; Christopher L Coe; Pamela J Kling
Journal:  J Pediatr       Date:  2018-06-14       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.